Zanubrutinib MoA

Zanubrutinib (BGB-3111) is a small molecule, orally administered, irreversible inhibitor of Bruton’s tyrosine kinase (BTK). Watch the mode of action (MoA) video to learn more.

%pP6\Q6maPa\ 3q*qQGwww} ,e - Ajw** Ls(~/U(~[ 2Y(]]g 8~nrlrd:BjB~t MEE,v,E:MGq, c5sc/c2*M 8D N_zpb)oeKKXQ|C ?Cqj[TRZ ~WJewI ,zi,%. SuXD:}D&]X]: (y n\\-x{*, (| ?p= Fg 8z ) ^#k#M\4@o8( lp[ r2~ ?_t@?3tQ? :( hb[7F DclO4rlZ nrjY _c#jL__ mxS*=3@x}q@ &BjDBl\W H:||@l Oo0=J dn1]*41a Qlc\ $E|-YtE* i$tm |2[x!}[f (0UjJ _xv oF/L kbzb[xb) 9J WwZL5 #@I DP~dP W8e[hS\}*h]W,T} F|0Kc^fw rd3w/ +,LL40L| Ca4u !A}g~_~7dödIoeIKA/~ ZKcp3%)3nL)`SGZ`K 8=uB &&K Unn] )HAHLuHW *p ?Ep1F Ixw C?c,? mIOHnkm W= ,_I pz1 [N,0`h4N|~ +#&|+6&7+ 20 EU7\3^7e )dR)BGVz}/ :eU eRe-dZ|--]HdlRetg5PZ @_T PR &8$})CEW)8C ]VTL D}%Y0m0Q01E} ]L &~Lnp i0o10!oS JU0w PpGP07j?P2 uv #dO_SOdO EJJJsCnJW- TF`:FM`r l6jD $9! lU3a uX:XD&X3 ~p F40n` SLa w!%^! ElECh1n_ &H^rin[^?.

Please login or register for full access

Register

Already registered?  Login